https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-10 / Prostate Cancer Prostatic Dis. 2007;10(3):224-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-10 / Prostate Cancer Prostatic Dis. 2007;10(3):224-362007-04-10 00:00:002019-02-15 09:24:05Immunology and immunotherapy approaches for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-04 / Br. J. Haematol. 2007 May;137(4):297-306
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-04 / Br. J. Haematol. 2007 May;137(4):297-3062007-04-04 00:00:002019-02-15 08:37:28Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Bull. Exp. Biol. Med. 2007 Apr;143(4):528-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Bull. Exp. Biol. Med. 2007 Apr;143(4):528-342007-04-01 00:00:002019-02-15 08:59:47Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / J. Neurosurg. 2007 Apr;106(4):638-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / J. Neurosurg. 2007 Apr;106(4):638-452007-04-01 00:00:002019-02-15 08:59:50Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Expert Opin Biol Ther 2007 Apr;7(4):439-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Expert Opin Biol Ther 2007 Apr;7(4):439-482007-04-01 00:00:002019-02-15 08:59:52Dendritic cell-based active specific immunotherapy for malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Prostate 2007 Apr;67(5):500-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Prostate 2007 Apr;67(5):500-82007-04-01 00:00:002019-02-15 09:24:10Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells–a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Cancer Biother. Radiopharm. 2007 Apr;22(2):200-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Cancer Biother. Radiopharm. 2007 Apr;22(2):200-52007-04-01 00:00:002019-02-15 09:22:08In vitro induction of apoptosis in tumor cells by inactivated NDV and IAV
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-29 / Gut 2007 Sep;56(9):1275-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-29 / Gut 2007 Sep;56(9):1275-822007-03-29 00:00:002019-02-15 09:23:45Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-15 / Clin. Exp. Immunol. 2007 Jun;148(3):494-500
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-15 / Clin. Exp. Immunol. 2007 Jun;148(3):494-5002007-03-15 00:00:002019-02-15 08:37:38Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-402007-03-15 00:00:002021-11-15 15:39:28Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
